Department of Stomatology, Zibo Central Hospital, No. 54, Gongqingtuan Road, Zhangdian District, Zibo City Shandong Province 255000, China.
Biomed Res Int. 2021 Feb 1;2021:8899863. doi: 10.1155/2021/8899863. eCollection 2021.
Chronic periodontitis (CP) is a long-lasting inflammatory disease that seriously affects oral health. This study is aimed at investigating the regulatory mechanism of metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) in CP.
Primary human periodontal ligament cells (PDLCs) were treated with lipopolysaccharide (LPS) to establish a CP model. Quantitative real-time PCR (qRT-PCR) was used to measure the expression of MALAT1 and miR-769-5p in gingival tissues of patients with CP and LPS-treated PDLCs. Cell viability was detected by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay. Enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of inflammatory cytokines. The protein levels of caspase-3, Bax, Bcl-2, and hypoxia-inducible factor (HIF) 3A were determined by western blot assay. Dual-luciferase reporter (DLR) assay was applied to validate the target relationships between miR-769-5p and MALAT1/HIF3A.
The expression of MALAT1 and HIF3A was enhanced, and the expression of miR-769-5p was reduced in gingival tissues of patients with CP and LPS-treated PDLCs. MALAT1 knockdown promoted cell viability and inhibited inflammation and cell apoptosis in LPS-treated PDLCs. MALAT1 targeted miR-769-5p and negatively regulated miR-769-5p expression. miR-769-5p overexpression promoted cell viability and inhibited inflammation and cell apoptosis in LPS-treated PDLCs. Besides, miR-769-5p targeted HIF3A and negatively modulated HIF3A expression. Both miR-769-5p inhibition and HIF3A overexpression reversed the inhibitory effects of MALAT1 silencing on LPS-induced PDLC injury in vitro.
MALAT1 knockdown attenuated LPS-induced PDLC injury via regulating the miR-769-5p/HIF3A axis, which may supply a new target for CP treatment.
慢性牙周炎(CP)是一种长期存在的炎症性疾病,严重影响口腔健康。本研究旨在探讨转移相关肺腺癌转录物 1(MALAT1)在 CP 中的调控机制。
用脂多糖(LPS)处理原代人牙周膜细胞(PDLCs)建立 CP 模型。采用实时定量 PCR(qRT-PCR)检测 CP 患者牙龈组织和 LPS 处理的 PDLCs 中 MALAT1 和 miR-769-5p 的表达。采用 3-(4,5-二甲基-2-噻唑基)-2,5-二苯基-2-H-四唑溴盐(MTT)法检测细胞活力。酶联免疫吸附试验(ELISA)法检测炎症细胞因子水平。Western blot 法检测 caspase-3、Bax、Bcl-2 和缺氧诱导因子(HIF)3A 的蛋白水平。双荧光素酶报告(DLR)试验验证 miR-769-5p 与 MALAT1/HIF3A 的靶标关系。
CP 患者牙龈组织和 LPS 处理的 PDLCs 中 MALAT1 和 HIF3A 表达增强,miR-769-5p 表达降低。MALAT1 敲低促进 LPS 处理的 PDLC 细胞活力,抑制炎症和细胞凋亡。MALAT1 靶向 miR-769-5p 并负调控 miR-769-5p 表达。miR-769-5p 过表达促进 LPS 处理的 PDLC 细胞活力,抑制炎症和细胞凋亡。此外,miR-769-5p 靶向 HIF3A 并负调控 HIF3A 表达。miR-769-5p 抑制和 HIF3A 过表达逆转了 MALAT1 沉默对 LPS 诱导的 PDLC 损伤的抑制作用。
MALAT1 敲低通过调节 miR-769-5p/HIF3A 轴减轻 LPS 诱导的 PDLC 损伤,这可能为 CP 治疗提供新的靶点。